Dextrose Monohydrate 10% Injection Shortage Update

What’s in Shortage

Dextrose Monohydrate 10% Injection (Brand Name: DEXTROSE) is currently listed on the FDA drug shortage database. This medication is an injection used across several therapeutic categories, including Endocrinology/Metabolism, Gastroenterology, and Pediatrics. The shortage was first posted on March 1, 2022, and the status was last updated on February 2, 2026.

Which Manufacturers Are Affected

While the drug remains on the shortage list, several manufacturers currently report that the product is available.

• Baxter Healthcare: Product is available. (Contact: 888-229-0001)
• Fresenius Kabi USA, LLC: Product is available; however, the manufacturer advises checking with wholesalers for current inventory. (Contact: 888-386-1300)
• B. Braun Medical Inc.: Product is available. (Contact: 800-227-2862)
• Otsuka ICU Medical LLC: Product is available. Note that this product is distributed by ICU Medical. (Contact: 1-866-829-9025 or ProductAvailability@icumed.com)

Why There’s a Shortage

The FDA source data does not provide a specific reason for the ongoing shortage of Dextrose Monohydrate 10% Injection.

What Patients Should Do

If you or a family member rely on Dextrose Monohydrate 10% Injection, please consider the following steps:

• Consult Your Healthcare Provider: Always speak with your doctor or healthcare provider regarding your treatment plan and any concerns about medication availability. Do not make changes to your medical regimen without professional guidance.
• Speak with Your Pharmacist: Pharmacists often have the most up-to-date information on local stock and can check with different wholesalers.
• Contact Manufacturers: If you are having difficulty locating the medication, you may use the contact information provided above to inquire about supply status.

Source

Information provided by the FDA Drug Shortage Database.